![Glenn Whaley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glenn Whaley
Direttore Finanziario/CFO presso
IMMUNIC, INC.
Patrimonio netto: 133 427 $ in data 31/07/2026
Profilo
Mr. Glenn Whaley, CPA, is a Chief Financial Officer at Immunic, Inc., a Member at New Jersey Society of Certified Public Accountants and a Member at The American Institute of Certified Public Accountants.
Mr. Whaley was previously employed as a Chief Financial Officer by Pernix Therapeutics Holdings, Inc., a Vice President-Finance by Alvogen, Inc., and a Controller by ImClone Systems, Inc. He received his undergraduate degree from Rutgers Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
IMMUNIC, INC. 0,07% | 29/06/2026 | 9.551 ( 0,07% ) | 133 427 $ | 31/07/2026 |
Posizioni attive di Glenn Whaley
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNIC, INC. | Direttore Finanziario/CFO | 17/04/2020 |
New Jersey Society of Certified Public Accountants
 New Jersey Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates professional organization for certified public accountants | Corporate Officer/Principal | - |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Precedenti posizioni note di Glenn Whaley
| Società | Posizione | Fine |
|---|---|---|
Alvogen, Inc.
 Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Corporate Officer/Principal | 01/03/2015 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Comptroller/Controller/Auditor | 01/05/2011 |
| PERNIX THERAPEUTICS HOLDINGS INC | Direttore Finanziario/CFO | - |
Formazione di Glenn Whaley
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
74
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
New Jersey Society of Certified Public Accountants
New Jersey Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates professional organization for certified public accountants | Commercial Services |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Alvogen, Inc.
Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Rutgers Business School
 Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunic, Inc.
 Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
